Effects of angiostatin gene transfer on functional properties and in vivo growth of Kaposi's sarcoma cells

Cancer Research

Volumn 61, Issue 14, 2001, Pages 5441-5446

  Indraccolo, Stefano ^a,d   Morini, Monica ^b   Gola, Eleonora ^d   Carrozzino, Fabio ^e   Habeler, Walter ^d   Minghelli, Simona ^e   Santi, Leonardo ^e,f   Chieco Bianchi, Luigi ^d   Cao, Yihai ^g   Albini, Adriana ^c   Noonan, Douglas M ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b Modulo di Progressione Neoplastica   (Italy)

^c Lab di Biologia Cardiovascolare   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

^e ADVANCED BIOTECHNOLOGY CENTER   (Italy)

^f UNIVERSITY OF GENOA   (Italy)

^g KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOSTATIN; SIGNAL PEPTIDE; VIRUS VECTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DRUG EFFICACY; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; KAPOSI SARCOMA; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

ANGIOSTATINS; ANIMALS; CELL DIVISION; CELL LINE; CELL MOVEMENT; CHEMOTAXIS; CULTURE MEDIA, CONDITIONED; GENETIC VECTORS; HUMANS; MICE; PEPTIDE FRAGMENTS; PLASMINOGEN; SARCOMA, KAPOSI; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0035878870     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
2. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
3. Inhibition of AIDS-Kaposi's sarcoma cell induced endothelial cell invasion by TIMP-2 and a synthetic peptide from the metalloproteinase propeptide: Implications for an anti-angiogenic therapy
4. TIMP-2 overexpression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis
5. Regulation of angiostatin production by matrix metalloproteinase-2 in a model of concomitant resistance
6. Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma
7. Angiostatin-converting enzyme activities of human matritysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9)
8. Kringle domains of human angiostatin. Characterization of the anti- proliferative activity on endothelial cells
9. Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD
10. Multiple forms of angiostatin induce apoptosis in endothelial cells
11. Angiostatin induces and sustains dormancy of human primary tumors in mice
12. Angiostatin binds ATP synthase on the surface of human endothelial cells
13. Angiostatin gene transfer: Inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest
14. Angiostatin diminishes activation of the mitogen-activated protein kinases ERK-1 and ERK-2 in human dermal microvascular endothelial cells
15. Angiogenesis in cancer, vascular, rheumatoid and other disease
16. Antiangiogenic gene therapy
17. Gene therapy strategies for tumor antiangiogenesis
18. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma
19. Kaposi's sarcoma-associated herpesvirus
20. The β-core fragment of human chorionic gonadotrophin (hCG) inhibits growth of Kaposi's sarcoma-derived cells and a new immortalized Kaposi's sarcoma cell line
21. N-Acetyl cysteine inhibits endothelial cell invasion and angiogenesis
22. Somatostatin controls Kaposi's sarcoma tumor growth through inhibition of angiogenesis
23. Inhibition of angiogenesis and vascular tumor growth by interferon-producing cells: A gene therapy approach
24. Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases
25. Increased levels of spliced RNA account for augmented expression from the MFG retroviral vector in hematopoietic cells
26. Improved retroviral vectors for gene transfer and expression
27. Rapid identification of viable retrovims-transduced cells using the green fluorescent protein as a marker
28. Permanent cell line expressing human factor VIII-related antigen established by hybridization
29. Inhibition of angiogenesis by class I interferons in models of Kaposi's sarcoma
30. DNA immunization of mice against SIVmac239 Gag and Env using Rev-independent expression plasmids
31. Generation of expression plasmids for angiostatin, endostatin and TIMP-2 for cancer gene therapy
32. Pseudotyping of Moloney leukemia vires-based retroviral vectors with simian immunodeficiency virus envelope leads to targeted infection of human CD4+ lymphoid cells
33. A rapid in vitro assay for quantitating the invasive potential of tumor cells
34. Tumor and endothelial cell invasion of basement membranes
35. Inhibition of cancer cell growth by all-trans retinoic acid and its analog N-(4-hydroxyphenyl) retinamide: A possible mechanism of action via regulation of retinoid receptors expression
36. Inhibition of tumor growth correlates with the expression level of a human angiostatin transgene in transfected B16F10 melanoma cells
37. Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice
38. Continuous administration of angiostatin inhibits accelerated growth of colorectal liver metastases after partial hepatectomy
39. Human prostate carcinoma cells express enzymatic activity that converts human plasminogen to the angiogenesis inhibitor, angiostatin
40. Angiostatin suppresses malignant glioma growth in vivo
41. A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer
42. Viral vector-targeted antiangiogenic gene therapy utilizing an angiostatin complementary DNA
43. Synergy between angiostatin and endostatin: Inhibition of ovarian cancer growth
44. Human angiostatin inhibits murine hemangioendothelioma tumor growth in vivo
45. Update on the pathogenesis and treatment of Kaposi sarcoma
46. Long-term efficacy on Kaposi's sarcoma of highly active antiretroviral therapy in a cohort of HIV-positive patients
47. Regression of AIDS-related Kaposi's sarcoma following antiretroviral therapy with protease inhibitors: Biological correlates of clinical outcome
48. Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi's sarcoma
49. HAART is effective as anti-Kaposi's sarcoma therapy only after remission has been induced by chemotherapy
50. Co-expression of endothelial cell and macrophage antigens in Kaposi's sarcoma cells
51. Pathogenesis of AIDS-related Kaposi's sarcoma